Another Gem From a 2,000 Page Bill: ‘Botox Carve-Out’ Survives in PelosiCare Bill

by Publius

A provision within Speaker Nancy Pelosi’s health care measure passed by the House the other week rehashes a months-old intramural battle between powerful Democrats over how biologic drugs will face competition from generic drug manufacturers.

Botox_Injection

While the House bill provides a brand drug maker-backed 12 years of monopoly data protection for these next generation therapies, one component of the bill, buried on page 1,534, beginning on line 15 under the heading, “Restrictions on biological products containing dangerous ingredients,” might raise more than eyebrows.

(more…)